iTi Health is developing two product-lines, plectin-targeted imaging and plectin-targeted therapeutics. iTi has exclusive, global rights to the targeting agent compositions and use of plectin in diagnostics and therapeutics of human disease. The iTi Health mission is to develop personalized therapies for diseases bearing significant unmet medical need, like Pancreatic, Ovarian, Esophageal and Head and Neck Cancers.